Dyno Therapeutics takes in $100m Series A

Dyno Therapeutics, Inc., a biotechnology company applying artificial intelligence to gene therapy, raised $100 million in Series A financing.

6 May 2021•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles